CRP and chronic obstructive pulmonary disease: A sub-study of the SUMMIT trial showed that fibrinogen and CRP were associated with an increased risk of mortality in COPD patients; however, it could not show an association between elevated fibrinogen or CRP levels and decreased FEV1, hospitalization, and exacerbation rate [55].